Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 601 to 615 of 749 results for adult social

  1. Filgotinib for treating moderately to severely active ulcerative colitis (TA792)

    Evidence-based recommendations on filgotinib (Jyseleca) for moderately to severely active ulcerative colitis in adults when conventional or biological treatment cannot be tolerated, or the disease has responded inadequately or lost response to treatment.

    Technology appraisal guidance
    Published
    1 June 2022
    View recommendations

    Sections for TA792

  2. Dimethyl fumarate for treating moderate to severe plaque psoriasis (TA475)

    Evidence-based recommendations on dimethyl fumarate (Skilarence) for treating moderate to severe plaque psoriasis in adults.

    Technology appraisal guidance
    Published
    6 September 2017
    View recommendations

    Sections for TA475

  3. What is the clinical and cost effectiveness of cognitive rehabilitation for people with Multiple sclerosis (MS)?

    activities. People with MS who have cognitive problems often engage in fewer social and vocational activities, are less likely to be in...

    Research recommendation
    Published
    9 June 2015

  4. Supporting young people to manage their conditions:- What is the relationship between transition and subsequent self-management?

    from guidance Transition from children's to adults' services for young people using health or social care services Number...

    Research recommendation
    Published
    21 March 2016

  5. Vadadustat for treating symptomatic anaemia in adults having dialysis for chronic kidney disease (TA1035)

    Evidence-based recommendations on vadadustat (Vafseo) for treating symptomatic anaemia in adults having dialysis for chronic kidney disease.

    Technology appraisal guidance
    Published
    23 January 2025
    View recommendations

    Sections for TA1035

  6. Care pathway:- In the UK, what is the optimal care pathway for young people and adults with coexisting severe mental illness and substance misuse?

    pathway:- In the UK, what is the optimal care pathway for young people and adults with coexisting severe mental illness and substance...

    Research recommendation
    Published
    10 February 2017

  7. What are the key factors, including additional care and support, that influence participation* and quality of life in people with neuropathic pain?

    interpersonal interactions and relationships, major life areas, community, and social and civil life. There is evidence suggesting that...

    Research recommendation
    Published
    26 October 2020

  8. Refractory [Irritable bowel syndrome] (IBS):- What factors contribute to refractory IBS?

    profile, psychological symptoms, childhood adversity, psychiatric history, social supports, quality of life and other relevant potential...

    Research recommendation
    Published
    9 June 2015

  9. Barriers and facilitators:- What are the barriers and facilitators for young people and adults with coexisting severe mental illness and substance misuse to obtain an optimal service (including optimal time frame for delivering interventions) to meet their needs and enable their recovery?

    facilitators:- What are the barriers and facilitators for young people and adults with coexisting severe mental illness and substance...

    Research recommendation
    Published
    10 February 2017

  10. Team composition for home-based intermediate care:- How effective and cost effective are different approaches, in terms of team structure and composition, to providing home-based intermediate care for adults?

    structure and composition, to providing home-based intermediate care for adults? Any explanatory notes(if applicable) Why this is...

    Research recommendation
    Published
    15 October 2018

  11. How cost effective are fluoride varnish programmes and tooth-brushing schemes?

    outcomes should include the use of non-dental health and social care services by children and adults, such as numbers...

    Research recommendation
    Published
    9 June 2015

  12. How can healthy habits that promote oral health be supported and encouraged in families with children at high risk of poor oral health?

    outcomes should include the use of non-dental health and social care services by children and adults, such as numbers...

    Research recommendation
    Published
    9 June 2015

  13. People who choose not to take antipsychotic medication:- What is the clinical and cost effectiveness of psychological intervention alone, compared with treatment as usual, in people with psychosis or schizophrenia who choose not to take antipsychotic medication?

    include symptoms, relapse rates, quality of life, treatment acceptability, social functioning and the cost effectiveness of the...

    Research recommendation
    Published
    9 June 2015

  14. Vandetanib for treating medullary thyroid cancer (TA550)

    Evidence-based recommendations on vandetanib (Caprelsa) for treating medullary thyroid cancer in adults.

    Technology appraisal guidance
    Published
    12 December 2018
    View recommendations

    Sections for TA550

  15. Structured clinical management interventions in probation service providers:- What is the effectiveness of structured clinical (case) management in improving mental health outcomes using interventions within probation service providers?

    cost-effectiveness- broader measures of social functioning. Source guidance details Comes from guidance Mental health of...

    Research recommendation
    Published
    16 May 2017